GNI GroupGNIIF 84 Days Payable is 86.49 as of Mar. 2026, which is 10% below its 10-year median of 96.55. GuruFocus rates GNIIF with a GF Score™ of 84/100 and a GF Value™ of $17.11. The stock has 5 warning signs investors should review. Among 705 Biotechnology companies, GNI Group ranks worse than 56.03% on this metric.
GNI Group's average Accounts Payable for the
three
months ended in Mar. 2026 was $9.0 Mil. GNI Group's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $9.5 Mil.
Hence, GNI Group's Days Payable for the
three
months ended in Mar. 2026 was 86.49.
The historical rank and industry rank for GNI Group's Days Payable or its related term are showing as below:
GNIIF'
s Days Payable Range Over the Past 10 Years
Min: 77.41 Med: 96.55 Max: 264.86
Current: 86.07
During the past 13 years, GNI Group's highest Days Payable was 264.86. The lowest was 77.41. And the median was 96.55.
GNIIF's Days Payable is ranked worse than 56.03% of 705
companies
in the Biotechnology industry
Industry Median: 113.36
vs GNIIF: 86.07
GNI Group's Days Payable
declined
from Mar. 2025 (146.58) to Mar. 2026 (86.49).
It may suggest that GNI Groupaccelerated paying its suppliers.
GNI Group Days Payable Related Terms
GNI Group Days Payable Historical Data
* Premium members only.
The historical data trend for GNI Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GNIIF vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, GNI Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GNI Group Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, GNI Group's Days Payable distribution charts can be found below:
* The bar in red indicates where GNI Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
GNI Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GNI Group (GNIIF) has a Days Payable of 86.49 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on GNI Group and its competitors. This is 10% below median its historical median of 96.55. Over the past decade, GNI Group's Days Payable has ranged from 77.41 to 264.86. According to the industry distribution chart, GNI Group ranks #395 out of 705 companies in the Biotechnology industry, placing it in the top 56%.
Is GNI Group's Days Payable too high?
GNI Group's current Days Payable of 86.49 is 10% below median its 10-year median of 96.55. Over the past 10 years, this metric has ranged from a low of 77.41 to a high of 264.86. The Biotechnology industry median Days Payable is 113.36. GNI Group's value of 86.49 is 23.7% below this industry median. Based on the distribution chart, GNI Group ranks #395 out of 705 companies in the Biotechnology industry, which is below the industry midpoint. Overall, GNI Group has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does GNI Group's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, GNI Group ranks #395 out of 705 companies for Days Payable. This places GNI Group in the lower half of its industry. The industry median Days Payable is 113.36. GNI Group's value of 86.49 is 23.7% below this benchmark. Historically, GNI Group's own Days Payable has ranged from 77.41 to 264.86 over the past decade. While the company's 10-year median is 96.55 vs. the industry median of 113.36, GNI Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.36, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GNI Group's current Days Payable of 86.49 is 23.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on GNI Group and its competitors. For the Biotechnology industry, the median Days Payable is 113.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GNI Group's current Days Payable is 86.49, which is 10% below median its own 10-year median of 96.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GNI Group stock overvalued right now?
GNI Group (GNIIF) has a current Days Payable of 86.49. The stock's GF Value™ is $17.11, compared to a current price of $15.50 — trading 9.4% below its estimated fair value. The current Days Payable is 86.49, which is 10% below median its 10-year median of 96.55 and 23.7% below the Biotechnology industry median of 113.36. GNI Group's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For GNI Group (GNIIF), the current Days Payable is 86.49 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GNI Group (GNIIF) Overvalued in 2026?
Based on GuruFocus' analysis, GNI Group stock appears to be undervalued.
The current stock price of $15.50 is trading 9.4% below its estimated GF Value™ of $17.11.
Key valuation signals for GNIIF:
Days Payable: 86.49 (10% below median its 10-year median of 96.55)
GF Value™: $17.11 vs. price of $15.50 (9.4% below fair value)
Industry Position: 23.7% below the Biotechnology median (#395 of 705)
No single metric tells the full story. See the GNIIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
84GF Score
Get the complete analysis for GNIIF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GNIIF has been successfully added to your 
